Results:
A total of 2,579 patients were included. There were 2,166 mild (84.0%),
144 moderate (5.6%), and 269 severe-to-critical (10.4%) patients,
respectively. The flow chart of the study is available in figure 1. The
demographic, epidemiological and clinical outcomes of patients are
available in Table 1. The following ethnicities were represented:
Caucasia (89.1%), South America (5.1%), North Africa (2.0%), Black
Africa (1.2%) or other (2.6%). There were 1,630 women (63.2%). The
mean age was 44.4±16.7 years old. The severe-to-critical patients were
older (71.7±13.7) than the moderate (63.9±18.5) and mild (39.6±12.0;
p=0.001) patients. The ratio female/male of mild, moderate and
severe-to-critical patients were 2/1, 1/1 and 1.1/1.6, respectively
(p<0.05).
The most prevalent comorbidities were hypertension (16.0%), diabetes
(5.9%), gastroesophageal disorders (i.e. reflux and gastric ulcer)
(5.0%) and heart disorders (4.9%). Moderate and severe-to-critical
COVID-19 patients had higher prevalence of hypertension (60.5versus 7.9), diabetes (27.6 versus 1.9), gastroesophageal
disorders (8.52 versus 4.0), renal (12.1 versus 0.5),
respiratory (14.0 versus 0.5), heart (16.0 versus 1.8),
liver (4.4 versus 0.8) and neurological disorders (13.7versus 0.6) than mild patients (p<0.05).